let's head over live to mumbai with ayesha iffaridi for a chec on the india business report. >> following it up from asia, down by 50 points for the nifty right now. almost over 1%, though it's recovered from the low point of the day. we were staring down by about a 2%. you are seeing heavyweight selling, beat up markets are selling off and you are seeing institutional selling coming in. so reliance industries or in gc, both of these counters are giving off a lot by way of momentum. you have counters from the entire real estate space like unitech and glenn mark pharmaceuticals, that is one count which is in focus and trade today. here is perhaps the reason why. forest labs currently says they did not show positive results in the phase 2b trials pop so any jerk reaction coming in on opening bell. the counter was down about 18 odd percent. still continues to suffer, down about 14% on last count. some bit of recovery in ranbaxy, idn and a couple of other counters which have which has sold off a bit in the last week or so. with that, it's back to you. >> ayesha faridi, thank you very much. an